The smart insulin pens market would grow at a CAGR of 13.53% over the predicted time frame. The market is expected to increase in value from US$ 110.81 Mn in 2022 to US$ 305.87 Mn in 2030.
The on smart insulin pens Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/1897
Report Scope of the Smart Insulin Pens Market
| Report Coverage | Details |
| Market Size in 2022 | USD 110.81 Million |
| Market Size by 2030 | USD 305.87 Million |
| Growth Rate from 2022 to 2030 | CAGR of 13.53% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2030 |
| Segments Covered | Type, Usability, Product, Connectivity Type, Indication, End User, Geography |
A recent report provides crucial insights along with application based and forecast information in the Global Smart insulin pens Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Smart insulin pens market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Smart insulin pens market are included as given below:
Smart insulin pens Market Key Players
- Emperra GmbH
- Bigfoot Biomedical
- Digital Medics Pty Ltd.
- Jiangsu Deflu Medical Device Co.
- Medtronic plc
- Eli Lilly and Company
- Novo Nordisk
- Pendiq
- Sanofi
- Berlin-Chemie
Market Segments
By Type
- First Generation Pens
- Second Generation Pens
By Usability
- Prefilled
- Reusable
By Product
- Smart Insulin Pen
- Adaptors for Conventional Pen
By Connectivity Type
- Bluetooth
- USB
By Indication
- Type 1 Diabetes
- Type 2 Diabetes
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Care Settings
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global smart insulin pens market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the smart insulin pens market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. End User Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Smart Insulin Pens Market
5.1. COVID-19 Landscape: Smart Insulin Pens Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Smart Insulin Pens Market, By Type
8.1. Smart Insulin Pens Market, by Type, 2022-2030
8.1.1. First Generation Pens
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Second Generation Pens
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Smart Insulin Pens Market, By Usability
9.1. Smart Insulin Pens Market, by Usability, 2022-2030
9.1.1. Prefilled
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Reusable
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Smart Insulin Pens Market, By Product
10.1. Smart Insulin Pens Market, by Product, 2022-2030
10.1.1. Smart Insulin Pen
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Adaptors for Conventional Pen
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Smart Insulin Pens Market, By Connectivity Type
11.1. Smart Insulin Pens Market, by Connectivity Type, 2022-2030
11.1.1. Bluetooth
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. USB
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Smart Insulin Pens Market, By Indication
12.1. Smart Insulin Pens Market, by Indication, 2022-2030
12.1.1. Type 1 Diabetes
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Type 2 Diabetes
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Smart Insulin Pens Market, By End User
13.1. Smart Insulin Pens Market, by End User, 2022-2030
13.1.1. Hospitals and Clinics
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Ambulatory Surgical Centers
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Home Care Settings
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Smart Insulin Pens Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.2. Market Revenue and Forecast, by Usability (2017-2030)
14.1.3. Market Revenue and Forecast, by Product (2017-2030)
14.1.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.1.5. Market Revenue and Forecast, by Indication (2017-2030)
14.1.6. Market Revenue and Forecast, by End User (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Usability (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Product (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.1.8. Market Revenue and Forecast, by Indication (2017-2030)
14.1.8.1. Market Revenue and Forecast, by End User (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Usability (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.1.10. Market Revenue and Forecast, by Indication (2017-2030)
14.1.11. Market Revenue and Forecast, by End User (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.2. Market Revenue and Forecast, by Usability (2017-2030)
14.2.3. Market Revenue and Forecast, by Product (2017-2030)
14.2.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.2.5. Market Revenue and Forecast, by Indication (2017-2030)
14.2.6. Market Revenue and Forecast, by End User (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Usability (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Product (2017-2030)
14.2.9. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.2.10. Market Revenue and Forecast, by Indication (2017-2030)
14.2.10.1. Market Revenue and Forecast, by End User (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Usability (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Product (2017-2030)
14.2.12. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.2.13. Market Revenue and Forecast, by Indication (2017-2030)
14.2.14. Market Revenue and Forecast, by End User (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Usability (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Product (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.2.16. Market Revenue and Forecast, by Indication (2017-2030)
14.2.16.1. Market Revenue and Forecast, by End User (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Usability (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Product (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.2.18. Market Revenue and Forecast, by Indication (2017-2030)
14.2.18.1. Market Revenue and Forecast, by End User (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.2. Market Revenue and Forecast, by Usability (2017-2030)
14.3.3. Market Revenue and Forecast, by Product (2017-2030)
14.3.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.3.5. Market Revenue and Forecast, by Indication (2017-2030)
14.3.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Usability (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Product (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.3.8. Market Revenue and Forecast, by Indication (2017-2030)
14.3.9. Market Revenue and Forecast, by End User (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Usability (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.3.11. Market Revenue and Forecast, by Indication (2017-2030)
14.3.11.1. Market Revenue and Forecast, by End User (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Usability (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Product (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Indication (2017-2030)
14.3.12.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Usability (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Product (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Indication (2017-2030)
14.3.13.6. Market Revenue and Forecast, by End User (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.2. Market Revenue and Forecast, by Usability (2017-2030)
14.4.3. Market Revenue and Forecast, by Product (2017-2030)
14.4.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.4.5. Market Revenue and Forecast, by Indication (2017-2030)
14.4.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Usability (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Product (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.4.8. Market Revenue and Forecast, by Indication (2017-2030)
14.4.9. Market Revenue and Forecast, by End User (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Usability (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.4.11. Market Revenue and Forecast, by Indication (2017-2030)
14.4.12. Market Revenue and Forecast, by End User (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Usability (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Product (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Indication (2017-2030)
14.4.13.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Usability (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Product (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Indication (2017-2030)
14.4.14.6. Market Revenue and Forecast, by End User (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.2. Market Revenue and Forecast, by Usability (2017-2030)
14.5.3. Market Revenue and Forecast, by Product (2017-2030)
14.5.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.5.5. Market Revenue and Forecast, by Indication (2017-2030)
14.5.6. Market Revenue and Forecast, by End User (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Usability (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Product (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.5.8. Market Revenue and Forecast, by Indication (2017-2030)
14.5.8.1. Market Revenue and Forecast, by End User (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Usability (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Connectivity Type (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Indication (2017-2030)
14.5.9.6. Market Revenue and Forecast, by End User (2017-2030)
Chapter 15. Company Profiles
15.1. Emperra GmbH
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Bigfoot Biomedical
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Digital Medics Pty Ltd.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Jiangsu Deflu Medical Device Co.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Medtronic plc
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Eli Lilly and Company
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Novo Nordisk
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Pendiq
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Sanofi
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Berlin-Chemie
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments